A clinical trial of intravenous vinorelbine tartrate plus tamoxifen in the treatment of patients with advanced malignant melanoma

The aim of the current trial was to assess the efficacy and toxicity of weekly intravenous vinorelbine tartrate with daily oral tamoxifen in the treatment of patients with advanced or metastatic malignant melanoma.

[1]  K. Rowland,et al.  Phase III clinical trial of the combination of cisplatin, dacarbazine, and carmustine with or without tamoxifen in patients with advanced malignant melanoma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  V. Sondak,et al.  Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: a Southwest Oncology Group study. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  B. Zee,et al.  Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  R. Benjamin,et al.  Treatment of uveal melanoma metastatic to the liver. A review of the M. D. Anderson cancer center experience and prognostic factors , 1995 .

[5]  E. McClay,et al.  Tamoxifen: is it useful in the treatment of patients with metastatic melanoma? , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  S. Howell,et al.  Tamoxifen modulation of cisplatin sensitivity in human malignant melanoma cells. , 1993, Cancer research.

[7]  E. Bröcker,et al.  Tamoxifen as a single agent for advanced melanoma in postmenopausal women. A phase II study of the EORTC Malignant Melanoma Cooperative Group , 1992, Melanoma research.

[8]  C. Boni,et al.  Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen. , 1992, The New England journal of medicine.

[9]  A. Buzaid,et al.  High‐dose cisplatin with dacarbazine and tamoxifen in the treatment of metastatic melanoma , 1991, Cancer.

[10]  M. Collier,et al.  Phase II trial of piritrexim in metastatic melanoma using intermittent, low-dose administration. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  M. Namer,et al.  Final report of the french multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases , 1990, Cancer.

[12]  M. Mastrangelo,et al.  The importance of tamoxifen to a cisplatin‐containing regimen in the treatment of metastatic melanoma , 1989, Cancer.

[13]  M. Morimoto,et al.  Experimental antitumor activity of Navelbine. , 1989, Seminars in oncology.

[14]  S. Prete,et al.  Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma. , 1984, Cancer treatment reports.

[15]  L. Baker,et al.  Vindesine in patients with metastatic malignant melanoma: a Southwest Oncology Group study. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  K. Calman,et al.  A multicentre phase II trial of vindesine in malignant melanoma. , 1982, European journal of cancer & clinical oncology.

[17]  C. Fabian,et al.  Southwest Oncology Group experience with tamoxifen in metastatic melanoma. , 1982, Cancer treatment reports.

[18]  J. Bitran,et al.  Tamoxifen in the treatment of malignant melanoma. , 1981, Cancer treatment reports.

[19]  G. Westbury,et al.  Updated results of vindesine as a single agent in the therapy of advanced malignant melanoma , 1980 .

[20]  J. Ingle,et al.  Phase II study of tamoxifen in patients with disseminated malignant melanoma. , 1980, Cancer treatment reports.

[21]  I. R. Mackay,et al.  Tamoxifen in malignant melanoma. , 1979, The New England journal of medicine.

[22]  R. Fisher,et al.  ŒSTROGEN RECEPTORS IN HUMAN MALIGNANT MELANOMA , 1976, The Lancet.

[23]  J C Briggs,et al.  Cutaneous melanoma. , 1993, Journal of the American Academy of Dermatology.

[24]  L. Balducci,et al.  Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: a southwest oncology group study. , 1982, Cancer treatment reports.

[25]  F. Meyskens,et al.  Tamoxifen in metastatic malignant melanoma. , 1980, Cancer treatment reports.

[26]  L. Nathanson,et al.  Pilot study of vinblastine and bleomycin combinations in the treatment of metastatic melanoma. , 1980, Cancer treatment reports.